NCT02157649View on ClinicalTrials.gov

Single Dose Trial of Extended Release Combination Tablet Codeine and Guaifenesin

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

August 31, 2014

Study Completion Date

September 30, 2014

Conditions
Cough
Interventions
DRUG

IR Tablet under Fasted conditions

Administration of IR Tablets combination of Codeine Phosphate/Guaifenesin 20mg/400mg every 4 hours for 12 hours total.

DRUG

ER Tablet under Fed Conditions

Administration of two ER Tablet combination of Codeine Phosphate/Guaifenesin 30mg/600mg

DRUG

ER Tablet under Fasted Conditions

Administration of two Codeine Phosphate/Guaifenesin 30mg/600mg ER Tablets under fasted conditions.

Trial Locations (1)

11910

Pharmaceutical Research Unit, Amman

Sponsors

Lead Sponsor

Nexgen Pharma, Inc
All Listed Sponsors
lead

Nexgen Pharma, Inc

INDUSTRY

NCT02157649 - Single Dose Trial of Extended Release Combination Tablet Codeine and Guaifenesin | Biotech Hunter | Biotech Hunter